Share transaction in Cantargia AB

Cantargia AB’s (“Cantargia”) co-founders, Professor Thoas Fioretos and Dr Marcus Järås, have sold 20 per cent of their shareholdings in the company, in accordance with their previously communicated intention and subject to the terms and conditions of their lock-up agreements.

As previously communicated in Cantargia’s prospectus (published on 16 January 2015), Thoas Fioretos and Marcus Järås have, in view of their long-standing involvement in Cantargia, had the intention to sell up to 20 per cent of their shareholdings in the company. Thoas Fioretos and Marcus Järås have now sold 20 per cent of their shares, in accordance with the terms and conditions of their lock-up agreements.

Through the sale Thoas Fioretos has reduced his shareholding from 915,750 shares to 732,600 shares while Marcus Järås has reduced his shareholding from 915,750 shares to 732,600 shares. Following the sale Thoas Fioretos and Marcus Järås each hold approximately 5.5 per cent of the shares of Cantargia. Thoas Fioretos and Marcus Järås have a long-term view on their remaining shareholdings, which are also subject to lock-up agreements with a term of 12 months from the first day of trading on Nasdaq First North Stockholm, which is tomorrow, 17 March 2015.

Sedermera Fondkommission has acted as advisor in connection with the transaction.

Certified Adviser
Sedermera Fondkommission is Cantargia’s Certified Adviser.

For further information, please contact
Göran Forsberg, CEO
Telephone: +46 (0)46 275 62 60
E-mail: goran.forsberg@cantargia.com

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE USA, AUSTRALIA, HONG KONG, JAPAN, CANADA, SINGAPORE, SOUTH AFRICA OR NEW ZEALAND OR IN ANY OTHER JURISDICTION WHERE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE ILLEGAL.

Tags:

About Us

Cantargia AB (publ), reg.no. 556791-6019, is a biotech company which is listed on Nasdaq Stockholm First North (ticker: CANTA). Sedermera Fondkommission is the company’s Certified Adviser. More information about Cantargia is available at http://www.cantargia.com.

Subscribe

Documents & Links